Download - WHOCC
Download - WHOCC
Download - WHOCC
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
QH03B<br />
ANTITHYROID PREPARATIONS<br />
Preparations used in the treatment of hyperthyrosis should be classified in this<br />
group.<br />
QH03BA<br />
QH03BB<br />
QH03BC<br />
QH03BX<br />
Thiouracils<br />
Sulfur-containing imidazole derivatives<br />
Perchlorates<br />
Other antithyroid preparations<br />
QH03C<br />
IODINE THERAPY<br />
Iodine preparations for systemic use should be classified in this group.<br />
QH03CA<br />
Iodine therapy<br />
QH04<br />
QH04A<br />
QH04AA<br />
PANCREATIC HORMONES<br />
GLYCOGENOLYTIC HORMONES<br />
Glycogenolytic hormones<br />
The pancreas glycogenolytic hormone glucagon is classified in this group. Insulins<br />
are classified in QA10A - Insulins and analogues.<br />
QH05<br />
CALCIUM HOMEOSTASIS<br />
Preparations acting on calcium homeostasis are classified in this group.<br />
Vitamin-D products, see QA11C - Vitamin A and D, incl. combinations of the two.<br />
QH05A<br />
QH05AA<br />
PARATHYROID HORMONES AND ANALOGUES<br />
Parathyroid hormones and analogues<br />
Extracts from parathyroid glands are classified in this group.<br />
87